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There are exciting new advances in multiple sclerosis (MS) resulting in a growing understanding of both
the complexity of the disorder and the relative involvement of grey matter, white matter and inﬂammation.
Increasing need for preclinical imaging is anticipated, as animal models provide insights into the pathophysi-
ology of the disease. Magnetic resonance (MR) is the key imaging tool used to diagnose and to monitor disease
progression in MS, and thus will be a cornerstone for future research. Although gadolinium-enhancing and T 2
lesions on MRI have been useful for detecting MS pathology, they are not correlative of disability. Therefore,
new MRI methods are needed. Such methods require validation in animal models. The increasing necessity
for MRI of animal models makes it critical and timely to understand what research has been conducted in
this area and what potential there is for use of MRI in preclinical models of MS. Here, we provide a review
of MRI and magnetic resonance spectroscopy (MRS) studies that have been carried out in animal models of
MS that focus on pathology. We compare the MRI phenotypes of animals and patients and provide advice on
how best to use animal MR studies to increase our understanding of the linkages between MR and pathology
in patients. This review describes how MRI studies of animal models have been, and will continue to be, used
in the ongoing effort to understand MS. 
c © 2014 Published by Elsevier Inc.
This is an open access article under the CC BY-NC-ND license
( http: // creativecommons.org / licenses / by-nc-nd / 3.0 / ). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1. Introduction 
Multiple sclerosis (MS) is an inﬂammatory, demyelinating and de-
generative condition of the central nervous system (CNS) for which
the cause is unknown. Animal models of MS have greatly enhanced
knowledge of the pathophysiology of the disease. Each of these an-
imal models provides different potential routes to investigate MS
disease processes. The experimental autoimmune encephalomyelitis
(EAE) model provides the opportunity to study inﬂammation, de-
myelination and axonal loss initiated by an autoimmune response to
central nervous system (CNS) components. Viral models, particularly
those induced by Theiler’s murine encephalomyelitis virus (TMEV),
enable examination of an immune response to a viral infection lead-
ing to demyelination. Demyelinating models caused by toxins such as
lysolecithin, cuprizone and ethidium bromide afford the opportunity
to investigate a primary demyelinating insult. 
Magnetic resonance imaging (MRI) plays an integral role in the* Corresponding author at: Department of Radiology, University of Calgary, 3330 
Hospital Drive, N.W., Calgary, Alberta T2N 4N1, Canada. 
E-mail address: dunnj@ucalgary.ca (J.F. Dunn). 
2213-1582/ $ - see front matter c © 2014 Published by Elsevier Inc. This is an open access artic
3.0 / ). 
http://dx.doi.org/10.1016/j.nicl.2014.04.011 diagnosis of MS, for tracking the disease course, and for determin-
ing the effectiveness of treatments (for a review, refer to Filippi and
Rocca, 2011 ). New MRI methods are continually being developed to
provide more information about MS disease processes with the goal
of improving the correlation of MRI with clinical disability. Ideally,
knowledge gained from MRI studies in animal models can be trans-
lated to human studies to improve the interpretation of MRI and to
inform human studies on elements of disease. 
Here, we review MRI and magnetic resonance spectroscopy (MRS)
studies of animal models of MS speciﬁcally with respect to investigat-
ing pathology. We relate these to what has been found in MS patients.
We previously reviewed the use of MRI studies of animal models of
MS for testing drugs in MS ( Nathoo et al., 2014 ). We also discuss how
MRI can be applied to answer questions about the pathophysiology of
MS using animal models of MS. Such studies at the preclinical stage
have the potential to direct subsequent application of MRI in the hu-
man MS population. le under the CC BY-NC-ND license ( http: // creativecommons.org / licenses / by-nc-nd / 
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p. MRI studies in animal models of MS 
.1. Experimental autoimmune encephalomyelitis (EAE) 
EAE is a model of chronic inﬂammation and is the animal model 
sed most often to investigate MS. Many variants of the EAE model 
xist that can display monophasic, relapsing–remitting, chronic- 
rogressive or chronic-relapsing disease courses depending on the 
nimal strain and immunogen used. Taken together, the diverse types 
f EAE models present the spectrum of clinical phenotypes observed 
n MS ( Kipp et al., 2012 ). EAE immunization uses components of the 
NS which stimulate the immune system via antigen presentation and 
utoimmunity. The antigen may be from CNS homogenate or puriﬁed 
yelin peptides, such as myelin basic protein (MBP), myelin oligoden- 
rocyte glycoprotein (MOG), or proteolipid protein (PLP). This results 
n an autoimmune condition which targets myelin. EAE has been in- 
uced and examined across species with earlier studies focusing on 
on-human primates. Rodent models, particularly those using mice, 
re now more commonly used due to the affordability and availability 
f genetically modiﬁed murine strains ( Ransohoff, 2012 ). 
MS and EAE share several characteristics, including the destruction 
f myelin sheaths and axonal degeneration ( Steinman and Zamvil, 
005 ). In addition, numerous CNS lesions are present which are dis- 
ributed in space and time ( Adams and Kubik, 1952 ; Baxter, 2007 ). MS 
nd several variant models of EAE have evidence supporting a genetic 
usceptibility inﬂuenced by major histocompatibility complex class 
I haplotype ( Steinman and Zamvil, 2005 ). Furthermore, CD4 + and 
D8 + T-cells can be seen in lesions in both conditions, some of which 
re reactive to myelin proteins ( Steinman and Zamvil, 2005 ). Studies 
ave demonstrated that at the molecular level, the process of leuko- 
yte migration into the CNS is similar in EAE to that in MS ( Agrawal 
t al., 2011 ). For example, activated leukocytes roll and adhere onto 
ndothelial cells via adhesion molecules, and then ultimately cross 
he glia limitans to enter the CNS parenchyma ( Agrawal et al., 2006 ). 
The vast majority of MRI studies with animal models of MS have 
sed the EAE model. Importantly, the EAE model shows the same 
linico-radiological paradox seen in MS, where MRI lesion load does 
ot always correspond to the level of clinical disability ( Wuerfel et 
l., 2007 ). 
.1.1. EAE: imaging non-speciﬁc pathological changes 
Key pathological processes in MS including inﬂammation, de- 
yelination, axonal loss and oedema have been assessed using T 2 - 
eighted imaging, where areas of injury appear hyperintense. Al- 
hough T 2 can identify each of these processes, it cannot differentiate 
etween them, which has made T 2 -weighted MRI a method to charac- 
erize cumulative damage to the CNS, but not to identify the individual 
rocesses responsible for the damage. 
In EAE models produced in rodents and primates, lesions have 
een detected using T 2 -weighted MRI, which have been shown to 
orrespond to inﬂammation, demyelination and axonal loss ( DeBoy 
t al., 2007 ; Hart et al., 1998 ; Stewart et al., 1991 ). These hyperin- 
ensities on T 2 -weighted MRI have frequently been observed in the 
eriventricular white matter ( Hart et al., 1998 ; Boretius et al., 2006 ; 
uharik et al., 1988 ; Verhoye et al., 1996 ), corresponding well with 
hat is observed in MS ( Barkhof et al., 1997 ). Other areas where T 2 
yperintensities have been seen in EAE animals include the corpus 
allosum ( Hart et al., 1998 ), cerebellum ( Waiczies et al., 2012 ) and 
erebral grey matter ( Hart et al., 1998 ), albeit much less frequently 
han in the periventricular white matter. 
In EAE, changes in T 2 have been observed to precede the onset of 
linical signs ( Stewart et al., 1991 ; Waiczies et al., 2012 ; Karlik et al., 
990 ; O’Brien et al., 1987 ). In marmosets with EAE, T 2 lesions in the 
hite matter appear to enlarge over time, with stable lesions being 
resent during later stages of lesion evolution ( Boretius et al., 2006 ). T 2 contrast does not appear to normalize, nor does lesion size de- 
crease over the EAE disease course ( Boretius et al., 2006 ). In addition, 
acute lesions are not distinguishable from older, more chronic lesions 
on T 2 -weighted MRI ( Kuharik et al., 1988 ). Interestingly, the propor- 
tion of animals where T 2 lesions are detected varies between studies, 
where the lowest proportion has been observed in rats ( Dousset et 
al., 1999a ) and guinea pigs ( O’Brien et al., 1987 ; Dousset et al., 1992 ), 
and the highest observed in primates ( Stewart et al., 1991 ; Hawkins 
et al., 1990 ). It is not clear if this discrepancy is attributable to species 
differences or to the parameters for the MRI sequence used for T 2 . 
Overall, T 2 -weighted MRI has shown similar trends in EAE as in MS. 
2.1.2. EAE: imaging blood brain barrier (BBB) breakdown 
BBB disruption is a cardinal feature of active inﬂammatory lesions 
in MS. T 1 -weighted MRI with gadolinium (Gd) is a component of 
the standard imaging protocol for MS to assess lesions with active, 
ongoing inﬂammation ( Polman et al., 2011 ). MRI has been used to 
assess BBB breakdown in EAE models across species. Interestingly, 
the presence of Gd-enhancing lesions and Gd enhancement in gen- 
eral is variable amongst studies. Gd-enhancing lesions are present in 
EAE induced in monkeys ( Hart et al., 1998 ; Blezer et al., 2007 ), dogs 
( Kuharik et al., 1988 ), guinea pigs ( Cook et al., 2005 ; Karlik et al., 
1993 ) and mice ( Wuerfel et al., 2007 ; Waiczies et al., 2012 ; Nessler 
et al., 2007 ; Smorodchenko et al., 2007 ). However, Gd-enhancing le- 
sions are not observed in some rat ( Dousset et al., 1999a ) and mouse 
( Schellenberg et al., 2007 ) EAE studies. 
Gd-enhancing lesions have been observed in the lumbar 
spinal cord ( Cook et al., 2005 ), brainstem ( Wuerfel et al., 2007 ; 
Smorodchenko et al., 2007 ), cerebellum ( Wuerfel et al., 2007 ; 
Smorodchenko et al., 2007 ), midbrain ( Wuerfel et al., 2007 ) and 
periventricular areas ( Wuerfel et al., 2007 ; Kuharik et al., 1988 ; 
Smorodchenko et al., 2007 ) ( Fig. 1 ). BBB breakdown has been shown 
to take place before the presence of clinical signs in EAE mice ( Wuerfel 
et al., 2007 ). Even in cases where Gd-enhancing lesions were present 
in EAE animals, not all of the animals showed such lesions. The per- 
centage of EAE animals with Gd-enhancing lesions is variable, rang- 
ing from 47% in guinea pigs ( Karlik et al., 1993 ) up to 100% in mice 
( Smorodchenko et al., 2007 ). It is likely that in EAE animals, lesions 
only have a disrupted BBB for a short time, and as standard time points 
are used for imaging, such BBB disruption may often be missed. This 
makes it difﬁcult to use enhancing lesions in EAE as a biomarker of 
disease progression. 
An interesting observation that has been made across numerous 
studies is that Gd enhancement occurs in areas other than in le- 
sions (shown with histology or T 2 -weighted MRI), including in white 
matter areas away from lesions ( Boretius et al., 2006 ), in the brain 
parenchyma ( Karlik et al., 1993 ), near the third ventricle ( Karlik 
et al., 1993 ) and in peripheral regions of the lumbar spinal cord 
( Schellenberg et al., 2007 ). In the study with Gd enhancement in 
the peripheral regions of the lumbar spinal cord, histology showed 
that inﬂammatory cells appeared in the same areas which had Gd en- 
hancement ( Schellenberg et al., 2007 ); the co-localization of inﬂam- 
mation (as visualized with histology) with areas of Gd enhancement 
has been shown by others as well ( Hawkins et al., 1990 ). 
Although Gd has proven to be useful for detecting loss of BBB 
integrity in MS, Gd-enhancing MRI is not frequently used in EAE 
studies because changes with Gd rarely correspond with T 2 lesions. 
Instead, more sensitive tools have been proposed for assessing BBB 
breakdown, such as the gadolinium-based contrast agent, gadoﬂuo- 
rine M (Gf). In rodents with EAE, Gf has been used to detect cere- 
bral ( Bendszus et al., 2008 ; Wuerfel et al., 2010 ) and spinal cord 
( Bendszus et al., 2008 ) lesions not seen with Gd or with T 2 -weighted 
MRI ( Bendszus et al., 2008 ) ( Fig. 2 ). Gf lesions correspond well with 
inﬂammation seen via staining for macrophages / microglia ( Bendszus 
et al., 2008 ; Wuerfel et al., 2010 ), especially in cases of severe inﬂam- 
mation ( Bendszus et al., 2008 ). These studies did not comment on 
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Fig. 1. Gadolinium (Gd)-enhancing lesions are present in the brainstem, cerebellum and periventricular area of EAE mice. (A) through (C) show images for naive mice following 
administration of Gd, where no enhancement is seen. (D) through (F) show images for EAE mice where Gd enhancement is seen with T 1 -weighted imaging in the brainstem, 
cerebellum and periventricular area (white arrows). 
(Adapted from Smorodchenko et al. (2007) .) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 possible co-localization between areas with Gf enhancement and the
presence of lymphocytes. However, EAE lesions have a considerable
presence of macrophages which may disrupt the BBB. Gf enhance-
ment is also present in cases of inﬂammation of the cranial nerves in
EAE mice ( Wuerfel et al., 2007 ). In circumventricular organs, particu-
larly in the choroid plexus, subfornicular organ and area postrema, Gf
enhancement has been observed. Gf signal intensity in the subfornic-
ular organ and area postrema was signiﬁcantly correlated with EAE
disease severity ( Wuerfel et al., 2010 ). The enhanced sensitivity of Gf
compared to Gd makes Gf a promising method for better detection
of BBB breakdown. Importantly, in many instances, BBB breakdown
is associated with inﬂammation, making inﬂammation an important
process to study as well.  
 2.1.3. EAE: imaging inﬂammation 
In EAE, inﬂammation has been studied extensively using iron
oxide-based nanoparticle contrast agents. These agents provide a
means to track migration of monocytes into the CNS during EAE and
to follow their behaviour as macrophages once in the CNS. In EAE ani-
mals, iron nanoparticles have been shown to accumulate in the spinal
cord ( Chin et al., 2009 ; Dousset et al., 1999b ; Engberink et al., 2010 ;
Millward et al., 2013 ), brainstem ( Chin et al., 2009 ; Dousset et al.,
1999a ; Millward et al., 2013 ; Brochet et al., 2006 ; Tysiak et al., 2009 ),
cerebellum ( Chin et al., 2009 ; Dousset et al., 1999a ; Engberink et al.,
2010 ; Millward et al., 2013 ; Brochet et al., 2006 ; Tysiak et al., 2009 ;
Oweida et al., 2007 ), corpus callosum ( Wuerfel et al., 2007 ), cortex
( Wuerfel et al., 2007 ; Tysiak et al., 2009 ), choroid plexus ( Millward et
al., 2013 ) and vascular endothelium ( Millward et al., 2013 ; Xu et al.,
1998 ). In some studies, Prussian Blue staining for non-heme iron was
746 N. Nathoo et al. / NeuroImage: Clinical 4 (2014) 743–756 
Fig. 2. Gadoﬂuorine (Gf) shows contrast-enhanced lesions that are not seen using T 2 -weighted imaging in EAE rat brain. (A) and (B) show T 1 -weighted images of an EAE rat after 
Gf administration where enhancement is seen in the periventricular region, cerebellum and brainstem, respectively. (C) and (D) show corresponding T 2 -weighted images on which 
the lesions are not seen. 
(Adapted from Bendszus et al. (2008 ).) 
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Berformed to provide histological conﬁrmation of the presence of iron 
anoparticles where MRI had shown hypointense signals ( Wuerfel et 
l., 2007 ; Chin et al., 2009 ; Engberink et al., 2010 ; Millward et al., 
013 ; Tysiak et al., 2009 ; Xu et al., 1998 ). However, staining with 
russian Blue can also indicate the presence of iron deposition un- 
elated to monocytes labelled with iron nanoparticles. To the best of 
ur knowledge, monocytes labelled with iron nanoparticles have not 
een differentiated from iron that has been naturally deposited due 
o the disease process itself in any studies. In particular, one must 
e cautious in interpreting iron staining as sites where macrophages 
ontain iron nanoparticles, as it is now known that iron deposition 
an occur in EAE mice in the lumbar spinal cord in regions of demyeli- 
ation ( Nathoo et al., 2013a ). 
Another challenge in using iron nanoparticles has been determin- 
ng whether they accumulate in blood-derived macrophages or in 
icroglia via a breached BBB. One study addressed this issue by using 
ransgenic mice which expressed enhanced green ﬂuorescent protein 
GFP) in haematopoietic-derived macrophages, but not in microglia 
 Oweida et al., 2007 ). It was observed that regions of hypointen- 
ities on MRI in the CNS corresponded with regions that showed 
ron as assessed using Prussian Blue staining and with regions that 
ere GFP-positive, indicating that the cells which had taken up the 
ron nanoparticles were blood-derived macrophages, not microglia 
 Oweida et al., 2007 ). 
MRI using iron nanoparticles has also been used to study regional 
ifferences in lesion formation in EAE. Using T 2 -weighted MRI, le- 
ions (hypointense areas) were observed in the caudal part of the 
rainstem at disease onset, while lesions appeared in the medulla 
nd midbrain later on in the disease course in EAE rats ( Baeten et 
l., 2008 ). Hypointense areas seen in MRI correlated with areas con- 
aining macrophages as visualized using ED-1 staining ( Baeten et al., 
008 ). 
Several studies have compared monocyte inﬁltration into the CNS 
using iron nanoparticles) and BBB breakdown (using Gd- or Gf- 
nhanced MRI). Most reported a discrepancy between the timing of 
BB breakdown and monocyte inﬁltration into the CNS ( Floris et al., 2004 ; Ladewig et al., 2009 ; Rausch et al., 2003 ), while one did not 
( Wuerfel et al., 2007 ). It has also been shown that some lesions vi- 
sualized using iron nanoparticles do not correspond to Gf-enhancing 
lesions ( Tysiak et al., 2009 ; Ladewig et al., 2009 ); this lends support 
to the concept that inﬂammatory cell transport can occur without a 
disrupted BBB. Thus, BBB breakdown can be due to inﬂammation, but 
inﬂammation does not always lead to BBB breakdown. 
Others have labelled T-cells using iron nanoparticles and imaged 
their migration in EAE in vivo. A study that labelled CD4 + T-cells 
with ultrasmall superparamagnetic iron oxide (USPIO) particles ob- 
served the presence of labelled cells in the brainstem, cerebellum 
and frontal and prefrontal areas of the brain using T 1 -weighted MRI 
with which areas of USPIO accumulation appeared hyperintense in 
EAE mice ( Pirko et al., 2003 ). Other studies used MBP-reactive T-cells 
labelled with iron nanoparticles to induce EAE in rodents; subse- 
quent T 2 -weighted MRI visualized focal hypointensities in the lum- 
bar ( Robinson et al., 2010 ) and sacral spinal cord ( Baeten et al., 2010 ), 
which corresponded to areas containing iron detected via Prussian 
Blue staining ( Robinson et al., 2010 ; Baeten et al., 2010 ). 
In one study, the locations of lesions were compared in rats that 
were naive when receiving labelled MBP-reactive T-cells versus those 
that were actively immunized for EAE when receiving labelled MBP- 
reactive T-cells ( Baeten et al., 2010 ). Naive rats had hypointensities 
only in the sacral spinal cord, whereas primed rats had hypointensi- 
ties in the brainstem, midbrain and sacral spinal cord ( Baeten et al., 
2010 ). In a different study, PLP-reactive T-cells were labelled with 
superparamagnetic iron oxide nanoparticles, and hypointense areas 
were seen in the white matter of the thoracic and lumbar spinal cord 
of EAE mice using T 2 * MRI, which corresponded to areas of histologi- 
cally veriﬁed inﬂammation and demyelination ( Anderson et al., 2004 ) 
( Fig. 3 ). 
Aside from their usage with monocytes and T-cells to study in- 
ﬂammation, paramagnetic contrast agents have also been tagged to 
antibodies directed against cell adhesion molecules which are upreg- 
ulated at the level of endothelial cells at the BBB in MS ( Cannella and 
Raine, 1995 ) and EAE ( Cannella et al., 1990 ). Vascular cell adhesion 
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Fig. 3. T-cells labelled with iron nanoparticles show hypointense lesions in the spinal 
cord of EAE mice that correspond to areas of inﬂammation and demyelination. (A) and 
(B) show T 2 *-weighted images of the thoracic–lumbar spinal cord in an EAE mouse, in 
vivo and ex vivo, respectively, where a long hypointense (dark) lesion is visible (white 
arrows). (C) shows haematoxylin and eosin staining, where inﬂammation correspond- 
ing to the lesion area is seen. (D) shows luxol fast blue staining for myelin with which 
demyelination is visible as a loss of blue stain. 
(Adapted from Anderson et al. (2004). ) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Lesions detected in the white matter of the lumbar spinal cord of EAE mice using 
susceptibility-weighted imaging correspond to areas of iron deposition and demyeli- 
nation. (A) shows the susceptibility-weighted MRI of the lumbar spinal cord of an EAE 
mouse where a lesion can be seen in the ventral white matter (white arrow). (B) shows 
DAB-enhanced Perl’s staining for the lesion area on which iron deposits can be seen as 
areas of brown. (C) shows luxol fast blue staining for myelin where demyelination can 
be seen by the loss of blue stain. 
(Adapted from Nathoo et al. (2013a) .) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 molecule-1 (VCAM-1) is one such adhesion molecule that is upregu-
lated in MS ( Battistini et al., 2003 ) and EAE ( Steffen et al., 1994 ), mak-
ing it a good target for studying inﬂammation. A VCAM-1 contrast
agent based on microparticles of iron oxide (VCAM-MPIO) showed
that VCAM-MPIO binding was present before the onset of clinical
signs of EAE in mice ( Serres et al., 2011 ). It was noted that binding
progressed in a rostral direction over the course of EAE — before clin-
ical signs, binding was present in the hindbrain and caudal part of
the forebrain, whereas at peak disease, binding was seen throughout
the forebrain ( Serres et al., 2011 ). Knowing that VCAM-MPIO binding
takes place in the brain, it would be useful to investigate the lumbar
spinal cord as well. Also, VCAM-MPIO binding was observed to pre-
cede the BBB breakdown that was visualized using Gd-enhanced MRI
( Serres et al., 2011 ). Imaging for VCAM-MPIOs has not been carried
out in humans yet, but the contrast agent was not observed to have
toxic effects in mice ( Serres et al., 2011 ). 
Imaging has also been carried out in EAE mice using a con-
trast agent for intercellular adhesion molecule-1 (ICAM-1) based on
an anti-ICAM-1 antibody-conjugated paramagnetic liposome (APCL)
with T 1 -weighted MRI ( Sipkins et al., 2000 ). Using this method, con-
siderable increases in signal intensity were seen in the cerebellar and
cerebral cortices, and ICAM-1 was upregulated on vessels both with
and without inﬁltration of immune cells ( Sipkins et al., 2000 ). Changes
in grey matter were thought to be due to increased vascularization
in the grey matter as compared to the white matter ( Sipkins et al.,
2000 ). This is supported by a study showing that angiogenesis takes
place in the grey matter in EAE mice ( Macmillan et al., 2011 ). 
2.1.4. EAE: imaging white matter changes 
Demyelination of the white matter is a common feature of MS. In
EAE, white matter changes have been studied using a variety of MRI
methods. However, one of the challenges is distinguishing changes
due to demyelination from those attributable to inﬂammation. One
of the MRI methods sensitive to changes in white matter, magneti-
zation transfer ratio (MTR), is reduced in MS ( Schmierer et al., 2004 )
and in EAE ( Blezer et al., 2007 ; Aharoni et al., 2013 ; Rausch et al.,
2009 ), suggesting a loss of tissue integrity. Myelin water imaging has
also been used to visualize white matter changes in MS ( Laule et
al., 2004 ) and in EAE ( Gareau et al., 2000 ). Upon comparing MTR and
myelin water fraction obtained from myelin water imaging, it appears
that MTR is sensitive to inﬂammation, while myelin water fraction is
instead more speciﬁc for myelin content ( Gareau et al., 2000 ). As
myelin water imaging is a relatively newer technique that appears to
be quite promising for characterizing white matter changes, it shouldbe explored further in EAE as well as other animal models of MS for
assessing demyelination, and potentially remyelination as well. 
White matter changes have also been assessed using
susceptibility-weighted imaging. Lesions detected with this tech-
nique in the ventral white matter of the lumbar spinal cord of
EAE mice correspond to areas of demyelination and iron deposition
( Nathoo et al., 2013a ) ( Fig. 4 ). 
2.1.5. EAE: imaging axonal damage 
The magnitude of axonal loss is widely considered to be the
main element responsible for a patient’s transition from relapsing–
remitting to secondary progressive MS ( Trapp et al., 1999 ). Axonal
damage and loss have been studied in MS using T 1 -weighted MRI,
with “black holes” or persistent hypointensities on T 1 being indica-
tive of severe axonal loss ( Sahraian et al., 2010 ). Such persistent hy-
pointensities have also been documented using T 1 -weighted MRI in
EAE mice. This study indicated that the pathological correlate of a
T 1 black hole was signiﬁcant demyelination and inﬂammation and
axonal loss ( Nessler et al., 2007 ). 
As diffusion is sensitive to the presence of myelin and cell orga-
nization, diffusion tensor imaging (DTI) shows promise for detecting
pathology in MS. Axial diffusivity, a metric obtained by DTI, is re-
duced throughout all of the white matter in EAE mice ( Budde et al.,
2008 ; Budde et al., 2009 ), and correlates with a decrease in SMI31
staining for phosphorylated neuroﬁlaments, indicative of axonal loss
( Budde et al., 2009 ). In addition, changes in axial diffusivity are well
correlated with clinical score in the MOG-induced EAE mouse model
( Budde et al., 2009 ) ( Fig. 5 ). Changes in axial diffusivity have been
variable in human studies of MS, with some studies reporting a de-
crease ( Tillema et al., 2012 ), others reporting an increase ( Liu et al.,
748 N. Nathoo et al. / NeuroImage: Clinical 4 (2014) 743–756 
Fig. 5. Axial diffusivity decreases in the ventrolateral white matter and the posterior 
area of the dorsal white matter in the lumbar spinal cord with increasing disease 
severity in EAE mice. Axial diffusivity maps of the spinal cords (segment L2) of EAE 
animals obtained using in vivo DTI are shown where clinical scores (CS) range from 
0 (least severe) to 4 (most severe). Areas with the highest axial diffusivity values are 
shown in red, while areas with the lowest axial diffusivity values are shown in green 
and blue. 
(Adapted from Budde et al. (2009) .) 
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G012 ), and some reporting no alteration ( Naismith et al., 2010 ). Al- 
hough some studies have shown that changes in axial diffusivity are 
elated to axonal loss, others have made the case that axial diffusiv- 
ty may not relate to axonal damage only ( Harrison et al., 2013 ). The 
ncertainty between changes in axial diffusivity and MS pathology 
emains to be addressed. 
.1.6. EAE: imaging optic neuritis 
Optic neuritis (ON) is characterized by inﬂammation and demyeli- 
ation of the optic nerve and is frequently a precursor for MS, with 50% 
f those with ON going on to develop MS after 15 years ( Optic Neuritis 
tudy Group, 2008 ). ON is one of the most common initial symptoms 
een in MS ( Ebers, 1985 ). In EAE, ON has been observed in numerous 
tudies using MRI. One study using T 2 and Gd-enhancing MRI showed 
hat half of the marmosets with EAE developed ON ( Boretius et al., 
006 ). Such enhancement of the optic nerve and optic tract has been 
bserved by others using Gf in EAE mice ( Wuerfel et al., 2007 ). Gf 
as been shown to be superior to Gd at detecting contrast enhancing 
esions in the optic nerve, with nine of ten total contrast enhancing 
esions in the optic nerve in EAE mice being detected using Gf, but not 
d ( Wuerfel et al., 2010 ). In EAE mice, damage to the optic nerve has also been observed 
using DTI which shows decreases in axial diffusivity and increases in 
radial diffusivity, believed to correspond to axonal damage and myelin 
damage respectively ( Sun et al., 2007 ). Such damage to the optic nerve 
has also been seen in humans; mean diffusivity and radial diffusivity 
are elevated while fractional anisotropy is reduced in the affected 
optic nerve ( Kolbe et al., 2009 ; Trip et al., 2006 ). Taken together, 
these studies indicate a loss of tissue integrity. The increase in radial 
diffusivity in the optic nerve seen in EAE parallels that seen in humans. 
However, in humans with optic neuritis, axial diffusivity is elevated 
in the affected optic nerve ( Kolbe et al., 2009 ), which contradicts what 
has been seen in EAE — the possible reasons for this require further 
investigation. 
2.1.7. EAE: imaging atrophy 
CNS atrophy is another key MS disease process which has been 
studied in EAE. However, fewer studies have been carried out than 
expected in this area in EAE considering that grey matter atrophy 
is perhaps best correlated with clinical disability in MS ( Tedeschi 
et al., 2005 ). Furthermore, atrophy appears to be accelerated when 
one is transitioning between stages of MS. When converting from 
clinically isolated syndrome to relapsing–remitting MS, grey matter 
atrophy is 3.4 fold greater than normal ( Fisher et al., 2008 ); when 
transitioning from relapsing–remitting MS to secondary progressive 
MS, grey matter atrophy is 12.4 fold greater than normal ( Fisher et 
al., 2008 ). 
Using T 2 -weighted MRI in models of EAE induced with MOG 
in mice, atrophy has been shown to take place in the cerebellar 
( MacKenzie-Graham et al., 2006 ; MacKenzie-Graham et al., 2009 ) 
and cerebral cortices ( MacKenzie-Graham et al., 2012 ); atrophy is 
also present at the level of the whole brain ( MacKenzie-Graham et al., 
2012 ). Volume changes in EAE mice are related to cumulative disease 
score when studying the cerebellum, but not at the level of the whole 
brain ( MacKenzie-Graham et al., 2012 ). In the cerebellar cortex, at- 
rophy was linked to apoptosis of Purkinje cells ( MacKenzie-Graham 
et al., 2009 ). An inverse correlation was also present between cere- 
bellar volume and disease duration, suggesting that as the disease 
progresses, atrophy develops ( MacKenzie-Graham et al., 2009 ). 
Atrophy has also been shown in EAE by measuring ventricle vol- 
ume, where lateral ventricle volume was two to seven fold larger in 
EAE mice induced using PLP than in controls ( Aharoni et al., 2013 ). 
However, such an increase in lateral ventricle volume was less pro- 
nounced in EAE mice induced using MOG ( Aharoni et al., 2013 ), sug- 
gesting that different CNS antigens can produce variations in EAE 
pathology. 
2.1.8. EAE: imaging vascular changes 
Vascular alterations and abnormalities have been observed in MS 
for a number of years ( Adams, 1988 ). This is a signiﬁcant area of in- 
vestigation as many lesions in MS are centred on venous vessels, and 
it has recently been suggested that the presence of a central vein in 
a lesion has strong predictive value for an MS diagnosis ( Mistry et 
al., 2013 ). Vascular abnormalities have been observed as large hy- 
pointense vessels in pre-contrast T 2 * MRI in EAE mice ( Xu et al., 
1998 ). Lesions have also been observed in association with intra- 
cortical vessels with T 2 * in EAE mice ( Waiczies et al., 2012 ). In the 
same study, venous abnormalities were seen in the brains of three 
of seven EAE mice using susceptibility-weighted imaging, either the 
day before or on the day of onset of motor disability ( Waiczies et 
al., 2012 ). Another study showed that many hypointensities detected 
using susceptibility-weighted imaging in the lumbar spinal cord and 
cerebellum of EAE mice were due to intravascular deoxyhaemoglobin, 
which was determined by imaging animals before and after perfusion 
of blood. These signal changes were region speciﬁc, localizing to the 
grey / white matter boundary in the spinal cord and to white matter 
tracts in the cerebellum ( Nathoo et al., 2013a ) ( Fig. 6 ). Vessels in the 
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Fig. 6. Vascular lesions due to intravascular deoxyhaemoglobin can be detected using 
susceptibility-weighted imaging in EAE mice. (A) shows hypointense spots around 
the grey / white matter boundary and pia mater of the lumbar spinal cord seen in 
vivo (before perfusion) which disappear after perfusion (white arrows). (B) shows 
hypointense spots in the white matter tracts of the cerebellum observed in vivo (before 
perfusion) which disappear after perfusion (white arrows). Taken together, these data 
indicate that many hypointensities detected with susceptibility-weighted imaging in 
EAE mice are due to deoxyhaemoglobin in blood vessels. 
(Adapted from Nathoo et al. (2013a) .) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7. Mice with TMEV develop ventricular enlargement concurrently with disease 
progression as seen using T 2 -weighted imaging with 3D MRI datasets. (A) shows the 
brain of a normal mouse where no ventricular enlargement is seen over the span of 
12 months. (B) shows the brain of a mouse with TMEV where ventricular enlargement 
can be seen on both the right and left sides, which gets progressively worse the longer 
the animal has the disease. 
(Adapted from Pirko et al. (2011) .) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 cerebellum also showed signiﬁcant perivascular cufﬁng ( Nathoo et
al., 2013a ). 
One study used 2D time-of-ﬂight MR angiography to show that
the branch positions of arteries in the lumbar spinal cord of EAE mice
were altered (shifting more towards the caudal direction of the spinal
cord), but these observations were not conﬁrmed with histology ( Mori
et al., 2014 ). 
2.1.9. EAE: imaging functional changes 
Alterations in axonal connection and function have been detected
in EAE using fMRI, in the form of manganese-enhanced MRI (MEMRI)
( Chen et al., 2008 ), where manganese contrast tracks along axons
with functionally connected synapses. In EAE rats, neuronal dysfunc-
tion observed using MEMRI was independent of myelin and axonal
damage ( Chen et al., 2008 ); this observation contrasts that seen in MS
where changes in functional connectivity and structural white matter
damage are related ( Ceccarelli et al., 2010 ). However, fMRI studies in
MS have used only BOLD MRI, not MEMRI, due to the neurotoxicity of
manganese ( Silva and Bock, 2008 ). To the best of our knowledge, no
studies have been conducted using BOLD MRI in EAE. 
2.1.10. EAE: imaging metabolites 
Using MRS, changes in metabolites have been studied in EAE.
1 H-MRS measures metabolites including n-acetylaspartate (NAA),
choline, myoinositol, lactate and glutamate. Studies using 1 H-MRS
in EAE have consistently come to the conclusion that NAA, a neu-
ronal marker, is reduced in EAE ( Chen et al., 2008 ; Brenner et al.,
1993 ; Preece et al., 1993 ; Richards et al., 1995 ). This is in agreement
with the ﬁnding in MS of reduced NAA at the level of the whole
brain ( Rigotti et al., 2012 ) and in the normal-appearing white mat-
ter ( Aboul-Enein et al., 2010 ). Increased levels of choline and choline
metabolites have also been seen in EAE ( Brenner et al., 1993 ; Preece
et al., 1993 ; Richards et al., 1995 ), as in MS ( Inglese et al., 2003 ;
Tartaglia et al., 2002 ), indicative of increased membrane turnover ( Lin
et al., 2005 ). Increases in the ratio between phosphocreatine and total31 P ( Husted et al., 1994 ) and in the ratio between phosphocreatine
and β-adenosine triphosphate ( Minderhoud et al., 1992 ) have been
observed in MS patients using 31 P-MRS, suggestive of alterations in
energy metabolism; 31 P-MRS has not yet been carried out in EAE. 
2.2. Theiler’s murine encephalomyelitis virus (TMEV) 
TMEV is a member of the Picornaviridae family of RNA viruses.
Administering TMEV intracerebrally in susceptible mouse strains
(like SJL / J) leads to demyelination ( Dal Canto et al., 1996 ; Denic et
al., 2011 ). Typically the disease is either monophasic or biphasic —
the biphasic condition shows chronic demyelination (presenting as
chronic-progressive), leading to the development of spinal cord le-
sions, similar to those observed in EAE ( Dal Canto et al., 1996 ; Denic
et al., 2011 ). 
2.2.1. TMEV: imaging changes in deep grey matter 
T 2 hypointensity in the deep grey matter of the brain has been ob-
served in mice with TMEV which develops as the disease progresses.
There is strong correlation between the degree of T 2 hypointensity
and impaired motor function ( Pirko et al., 2009 ). TMEV is the only
animal model of MS in which such MRI-detectable deep grey mat-
ter changes have been shown. This observation is signiﬁcant, as the
phenomenon of abnormalities in deep grey matter structures is com-
monly observed in MS using MRI, and has been shown to be related to
disease duration and grey matter atrophy ( Khalil et al., 2009 ). Corre-
sponding histological data have shown that these MRI changes in MS
patients are due to excess iron deposition ( Walsh et al., 2013 ). It is not
currently known if MRI-detectable deep grey matter abnormalities in
TMEV are due to iron deposition. 
2.2.2. TMEV: imaging atrophy 
As is the case in EAE, brain atrophy has been studied in TMEV.
In mice with TMEV, atrophy via ventricular enlargement has been
observed using T 2 -weighted imaging 3 months into the disease course
and peaked at 6 months ( Pirko et al., 2011 ) ( Fig. 7 ). Atrophy was
strongly correlated with impaired motor function ( Pirko et al., 2011 ).
It is interesting to note that brain atrophy is present in TMEV and in
EAE, whereas brain lesions are usually less common than spinal cord
lesions in both of these models ( Pirko et al., 2011 ). 
2.2.3. TMEV: imaging inﬂammation 
Inﬂammation has been investigated in TMEV using MRI. Studies
with Gd were carried out using interferon-gamma receptor knock-
out mice, as they develop brain lesions ( Pirko et al., 2004a ). Utiliza-
tion of this knockout allowed for a phenotype more similar to MS
than typical TMEV presentation, where lesions localize primarily to
the spinal cord. Gd enhancement was not observed for every lesion;
when observed, enhancement was seen early, but not late during the
evolution of lesions, and never lasted longer than 7 days ( Pirko et al.,
2004a ). Furthermore, four types of lesions were observed using T 2 :
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Fig. 8. Cuprizone-treated mice have elevated T 2 * values and signiﬁcantly reduced- 
grey–white matter contrast in the cortex and corpus callosum compared to control 
mice. (A) shows T 2 * maps for control mice obtained ex vivo. T 2 * values are shorter 
(darker on T 2 * maps) in the cortex and corpus callosum of controls compared to images 
shown in (B) which are the T 2 * maps for cuprizone-treated mice obtained ex vivo. Also, 
grey–white matter contrast is reduced in cuprizone-treated mice compared to control 
mice. 
(Adapted from Lee et al. (2012) .) ) expanding lesions, 2) expanding–retracting lesions, 3) ﬂuctuating 
esions and 4) stable lesions, with expanding lesions being the most 
ommon type to show Gd-enhancement ( Pirko et al., 2004a ). In ad- 
ition, USPIOs have been used in TMEV to track inﬂammation and 
igration of speciﬁc cell types, including CD8 + T-cells and CD4 + 
-cells ( Pirko et al., 2004b ). 
.2.4. TMEV: imaging black holes 
Another interesting pathological feature of MS investigated in 
MEV is the formation of hypointensities in T 1 , or “black holes,”which 
re related to axonal loss ( Pirko et al., 2004c ). However, unlike the 
ersistent black holes occasionally observed in MS ( Bagnato et al., 
003 ), T 1 black holes observed in TMEV in the periventricular and 
arahippocampal areas resolved by 45 days into the disease ( Pirko et 
l., 2004c ). It is possible that T 1 hypointensities seen in TMEV are sim- 
lar in nature to acute black holes seen in MS which typically resolve 
ithin 2 months after enhancement is no longer present ( Zhang et al., 
011 ). Interestingly, these T 1 black holes had reduced NAA / creatine 
atios as seen using MRS which normalized at the same time black 
oles disappeared on T 1 ( Pirko et al., 2004c ). In a later study, the cause 
f T 1 hypointensities in TMEV was determined to be due to CD8 + 
 cells by virtue of their expression of perforin ( Pirko et al., 2008 ), 
hich creates a pore in the plasma membrane, eventually leading to 
ell death ( Stepp et al., 2000 ). 
.2.5. TMEV: imaging neuronal loss 
Neuronal loss has been detected in the hippocampi of mice in- 
ected intracranially with TMEV. Regions with neuronal loss appeared 
s hyperintensities on T 2 -weighted MRI, which also had reduced NAA 
s seen with 1 H-MRS; it was speciﬁcally the CA1 layer where neurons 
ere lost, as conﬁrmed by histology ( Buenz et al., 2009 ). 
.2.6. TMEV: imaging white matter changes 
Although T 2 hyperintensities have been shown in the TMEV model 
hich are presumed to relate to demyelination, there have not been 
ny discussions linked to these hyperintensities being linked to de- 
yelination speciﬁcally ( Pirko et al., 2004a ). Histopathology has 
hown spinal cord lesions with demyelination in the TMEV model 
 Dal Canto and Lipton, 1975 ). Thus, more studies need to be con- 
ucted with MRI to speciﬁcally investigate white matter changes in 
MEV. 
.3. Cuprizone 
The cuprizone model is often employed to study speciﬁc aspects 
elated to demyelinating and remyelinating events in MS. Cuprizone 
s a copper chelator which, when consumed in an animal’s diet, pro- 
uces demyelination in the corpus callosum and superior cerebellar 
eduncles ( Blakemore, 1973 ; Matsushima and Morell, 2001 ); corti- 
al demyelination has also been observed ( Skripuletz et al., 2008 ). 
cute demyelination involves ingestion of cuprizone for 6 weeks 
ollowed by a normal diet for 6 weeks. This paradigm leads to de- 
yelination followed by spontaneous remyelination ( Matsushima 
nd Morell, 2001 ). Chronic demyelination results if cuprizone inges- 
ion takes place for 12 consecutive weeks ( Matsushima and Morell, 
001 ). 
One advantage of the cuprizone model for imaging studies is the 
implicity of the disease induction. It is a good model to follow both 
cute and chronic demyelination, and enables investigations of the 
ffects of oligodendrocyte apoptosis ( Matsushima and Morell, 2001 ). 
.3.1. Cuprizone: imaging white matter changes 
In cuprizone, the main processes studied using MRI have been 
emyelination and remyelination. Using DTI, it has been observed that 
adial diffusivity increases during demyelination ( Song et al., 2005 ; 
un et al., 2006 ; Xie et al., 2010 ) and decreases with remyelination ( Song et al., 2005 ). Changes in radial diffusivity have been shown to 
correspond with histological changes in myelin ( Sun et al., 2006 ). A 
study comparing i n vivo and ex vivo DTI in cuprizone found that ex 
vivo radial diffusivity was more reliable for assessing demyelination 
than in vivo radial diffusivity ( Zhang et al., 2012 ). Diffusion basis 
spectrum imaging, a method that can detect pathology missed with 
DTI, has been used in cuprizone, ﬁnding that radial diffusivity derived 
from diffusion basis spectrum imaging had greater correlation with 
histology for myelin than radial diffusivity derived from DTI ( Wang 
et al., 2011 ). In addition, diffusion basis spectrum imaging detected 
demyelination in the middle segment of the corpus callosum which 
was missed with DTI ( Wang et al., 2011 ). As diffusion basis spectrum 
imaging is a relatively newer method, more studies should be carried 
out comparing this with DTI in the cuprizone model. 
Magnetization transfer imaging (MTI) has also been used for moni- 
toring changes in white matter following cuprizone intoxication. MTR 
was signiﬁcantly decreased during demyelination and increased with 
remyelination in the cuprizone model ( Zaaraoui et al., 2008 ). These 
changes were strongly correlated with histology for myelin ( Zaaraoui 
et al., 2008 ). An interesting approach for characterizing the status 
of myelin in cuprizone was carried out using T 1 , T 2 and MTR, with 
the combined use of these three methods showing up to 95% predic- 
tion strength in establishing the myelin status of a lesion ( Merkler et 
al., 2005 ). This combined approach fared well in distinguishing de- 
myelination from remyelination ( Merkler et al., 2005 ). Another study 
used T 1 , multi-component T 2 , DTI and quantitative MTI in mice ex- 
posed to cuprizone for up to 6 weeks ( Thiessen et al., 2013 ). Fractional 
anisotropy was signiﬁcantly reduced while mean, axial and radial dif- 
fusivities were signiﬁcantly increased. In addition, signal intensity in 
T 2 was signiﬁcantly elevated and MTR was signiﬁcantly reduced in the 
corpus callosum. With quantitative MTI, the transfer rate between the 
bound and free pools (k) and the bound pool fraction (f) were signif- 
icantly decreased in the corpus callosum and external capsule; there 
was a signiﬁcant correlation between f and the myelin sheath frac- 
tion ( Thiessen et al., 2013 ), suggesting that a reduction in f is related 
to myelin loss. Using T 2 * in cuprizone, it has been observed that de- 
myelination leads to signiﬁcantly increased T 2 * in white matter while 
there is a drastic decrease in grey–white matter frequency contrast, 
indicating that myelin is the major source of such frequency contrasts 
( Lee et al., 2012 ) ( Fig. 8 ). 
2.3.2. Cuprizone: imaging changes in deep grey matter 
A study recently investigated demyelination in deep grey matter 
structures in cuprizone using MTI, ﬁnding that MTR values decreased 
signiﬁcantly in cuprizone mice compared to controls. MTR decreased 
by 0.39% each week of cuprizone exposure (6 weeks), but increased 
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Fig. 9. Tractography obtained using diffusion tensor imaging shows a lysolecithin 
lesion in mouse spinal cord with a loss of white matter tracts at 7 days post-injection. 
(A) shows a lysolecithin spinal cord in the axial orientation 7 days post-injection, where 
the lesion area is bright on the image and does not appear to contain white matter tracts 
(black arrow). The surrounding spinal cord area has tracts projecting from it. (B) shows 
the same spinal cord lengthwise, where the lesion area is visible as a large gap (black 
arrow). 
(Adapted from Nathoo et al. (2013b) .) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 after ending cuprizone treatment (for 2 weeks). MTI results showed
a signiﬁcant weak positive correlation with staining for myelin using
PLP immunohistochemistry ( Fjaer et al., 2013 ). These results are sig-
niﬁcant as deep grey matter demyelination has been shown to take
place in MS with histopathology ( Vercellino et al., 2009 ). 
2.3.3. Cuprizone: imaging axonal damage 
Axonal damage has been studied in cuprizone using MRI. With
diffusion weighted imaging, reduced parallel apparent diffusion co-
efﬁcient was observed with cuprizone treatment in the caudal part of
the corpus callosum ( Wu et al., 2008 ). Furthermore, a positive corre-
lation was observed between parallel apparent diffusion coefﬁcient
and neuroﬁlament staining, indicative of axonal density ( Wu et al.,
2008 ). 
Using in vivo DTI, axial diffusivity was shown to be a better indi-
cator of axonal injury compared with ex vivo axial diffusivity ( Zhang
et al., 2012 ). Axial diffusivity has been shown to be reduced at the
4 week time point, which has been supported by histology for axonal
damage ( Sun et al., 2006 ). Another study corroborated that axial diffu-
sivity was reduced during the acute phase of cuprizone demyelination
(up to 6 weeks), but that this correlation was lost after the 6 week
time point ( Xie et al., 2010 ). More studies need to be conducted to
assess axial diffusivity during the chronic demyelinating phase. Taken
together, these studies support the use of in vivo axial diffusivity as a
marker of axonal injury during the acute demyelinating phase in the
cuprizone model. 
2.4. Lysolecithin 
The lysolecithin model produces a demyelinating lesion via in-
jection of an activator of phospholipase A2, lysophosphatidylcholine,
into a speciﬁc area in the CNS which may include the dorsal and
ventral columns of the spinal cord, corpus callosum and internal cap-
sule ( Denic et al., 2011 ). The lysolecithin model involves demyelina-
tion and remyelination which follows a known disease course lasting
roughly 1 month. From an imaging perspective, this model is excellent
for validating methods that detect demyelination and remyelination. 
2.4.1. Lysolecithin: imaging white matter changes 
Studies using MTI have shown a reduction in MTR with demyelina-
tion in rodents and monkeys ( Deloire-Grassin et al., 2000 ; Dousset et
al., 1995 ; McCreary et al., 2009 ). However, there is variation on how
MTR changes with remyelination, with one study citing that MTR
increases with remyelination in lysolecithin-injected rats ( Deloire-
Grassin et al., 2000 ), while the other using lysolecithin-injected mice
did not observe a signiﬁcant change in MTR over the disease course
after the 14 day time point ( McCreary et al., 2009 ). These studies share
the observation that MTR values do not return to the values observed
at baseline which is supported by histology indicating incomplete
remyelination ( Deloire-Grassin et al., 2000 ; McCreary et al., 2009 ).
That there is disagreement between studies on how MTR changes
when remyelination takes place indicates that this area needs to be
investigated further. 
Myelin water fraction has been used alongside MTR, where it was
observed that values returned to baseline by 28 days after injection
(the time point at which remyelination would be as close to complete
as possible), while MTR values did not return to baseline ( McCreary
et al., 2009 ). It is known, based on histology, that while remyelination
does take place in this model, it is not complete ( Blakemore, 1978 ).
Therefore, it is worth investigating why myelin water fraction returns
to baseline when it is known that remyelination is incomplete. 
Diffusion weighted imaging has also been applied to the
lysolecithin model. The apparent diffusion coefﬁcient was elevated
in the region surrounding the lesion compared to the lesion area
itself early on in the disease course, which was attributable to
oedema ( Degaonkar et al., 2002 ). This observation of early oedemahas been replicated in another study using diffusion weighted imag-
ing ( Tourdias et al., 2011 ). Upon remyelination, apparent diffusion
coefﬁcient values in the lesion area and in the area surrounding the
lesion were dramatically reduced ( Degaonkar et al., 2002 ). Using DTI,
fractional anisotropy and axial diffusivity are shown to decrease while
radial diffusivity increases in lysolecithin-injected rats ( DeBoy et al.,
2007 ). Tractography, which provides a visual representation of white
matter tracts with DTI, has shown that the lesion area at the time
of maximum demyelination in lysolecithin appears to have a loss of
white matter tracts ( Nathoo et al., 2013b ) ( Fig. 9 ). Taken together,
methods that have been used to investigate white matter changes
over the lysolecithin disease course are promising, but further work
needs to be done to identify which method(s) can reliably provide a
measure of remyelination and repair. 
2.4.2. Lysolecithin: imaging BBB breakdown 
The BBB breakdown that would typically accompany oedema in
the lysolecithin model has also been studied using Gd. There appears
to be controversy as to whether lysolecithin lesions show enhance-
ment with Gd which would be indicative of BBB breakdown. One
study reported no Gd enhancement in lysolecithin-injected monkeys
( Dousset et al., 1995 ), while another reported Gd enhancement in
early lesions in lysolecithin-injected rats ( Ford et al., 1990 ). A recent
study which incorporated Evans blue staining for BBB permeability
showed that the BBB is compromised early in the lysolecithin disease
course, which resolved later in the disease course, at approximately
the same time as oedema declined ( Tourdias et al., 2011 ). With only a
few studies conducted in this area using MRI and given their differing
results, it would be useful to examine BBB breakdown in this model
further. 
2.5. Imaging of other animal models used to study MS 
In the realm of animal work in MS, there is always the possi-
bility of creating new animal models, or combining established ani-
mal models to give a new phenotype. One study combined EAE and
cuprizone, using DTI to assess pathology. Primary demyelination af-
ter cuprizone led to changes in radial diffusivity, but not axial dif-
fusivity ( Boretius et al., 2012 ). However, mice with demyelination,
inﬂammation and axonal damage showed less drastic changes in ra-
dial diffusivity ( Boretius et al., 2012 ). Therefore, it is possible that
radial diffusivity serves as a good marker of demyelination alone, but
when other disease processes are present, as is the case in MS, it is
less useful. The observation that radial diffusivity is useful in cases of
a primary demyelinating insult has also been made using DTI in the
lysolecithin model ( Nathoo et al., 2013b ). 
There is also the possibility of studying MS disease processes us-
ing transgenic mice that show certain MS disease processes with-
out active induction of disease. One such model involves using the
ND4 mouse that has many copies of the DM-20 isoform of PLP,
which leads to spontaneous demyelination at around 3 months of
age ( Mastronardi et al., 1993 ). Using T 2 in this model, demyelina-
tion was observed in the corpus callosum and cerebellum starting at
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Table 1 
Summary of pathologies and MRI phenotypes in animal models of MS. 
Animal model Pathology MRI method(s) and phenotype References 
EAE BBB breakdown Enhancement with Gd Wuerfel et al. (2007) , Hart et al. (1998) , 
Kuharik et al. (1988) , Waiczies et al. (2012) , 
Blezer et al. (2007) , Cook et al. (2005) , 
Karlik et al. (1993) , Nessler et al. (2007) , 
and Smorodchenko et al. (2007) 
Enhancement with Gf Bendszus et al. (2008) and Wuerfel et al. 
(2010) 
Inﬂammation Hypointensities with T 2 - or 
T 2 *-weighted MRI or hyperintensities 
in T 1 -weighted MRI in combination 
with iron nanoparticles 
Wuerfel et al. (2007) , Chin et al. (2009) , 
Dousset et al. (1999a) , Engberink et al. 
(2010) , Millward et al. (2013) , Brochet et al. 
(2006) , Tysiak et al. (2009) , Oweida et al. 
(2007) , and Xu et al. (1998) 
White matter changes Decrease in MTR Blezer et al. (2007) , Aharoni et al. (2013) , 
and Rausch et al. (2009) 
Axonal damage Black holes on T 1 -weighted MRI Nessler et al. (2007) 
Decrease in axial diffusivity with DTI Budde et al. (2008) and Budde et al. (2009) 
Optic neuritis Hyperintensity on T 2 -weighted MRI Boretius et al. (2006) 
Enhancement with Gd or Gf Wuerfel et al. (2007) , Boretius et al. (2006) , 
and Wuerfel et al. (2010) 
Decrease in axial diffusivity and 
increase in radial diffusivity with DTI 
Sun et al. (2007) 
Atrophy Cerebellar cortical atrophy, cerebral 
cortical atrophy and whole brain 
atrophy with T 2 -weighted MRI 
MacKenzie-Graham et al. (2006) , 
MacKenzie-Graham et al. (2009) , and 
MacKenzie-Graham et al. (2012) 
Vascular changes Hypointensities with T 2 *-weighted 
MRI and susceptibility-weighted MRI 
Waiczies et al. (2012) , Xu et al. (1998) , and 
Nathoo et al. (2013a) 
2D time-of-ﬂight angiography for 
altered branch positions of spinal 
arteries 
Mori et al. (2014) 
Functional changes Neuronal dysfunction with MEMRI Chen et al. (2008) 
Changes in metabolites Reduction in NAA with 1 H-MRS Chen et al. (2008) , Brenner et al. (1993) , 
Preece et al. (1993) , and Richards et al. 
(1995) 
TMEV BBB breakdown and inﬂammation Hyperintensities on T 2 -weighted MRI 
and enhancement with Gd 
Pirko et al. (2004a) 
Atrophy Ventricular enlargement with 
T 2 -weighted MRI 
Pirko et al. (2011) 
Black holes Hypointensities with T 1 -weighted MRI 
that resolve during the disease course 
Pirko et al. (2004c) 
Changes in deep grey matter Hypointensity on T 2 -weighted MRI Pirko et al. (2009) 
Neuronal loss Hyperintensities on T 2 -weighted MRI 
and reduction in NAA with 1 H-MRS 
Buenz et al. (2009) 
White matter changes Hyperintensities have been seen on 
T 2 -weighted MRI, but have not been 
discussed with respect to 
demyelination speciﬁcally 
Pirko et al. (2004a) 
Histology shows demyelination in 
spinal cord lesions 
Dal Canto and Lipton (1975) 
Cuprizone White matter changes Increase in radial diffusivity, increase 
in axial diffusivity and decrease in 
fractional anisotropy with DTI with 
demyelination 
Song et al. (2005) , Sun et al. (2006) , Xie et 
al. (2010) , and Thiessen et al. (2013) 
Decrease in MTR with demyelination Zaaraoui et al. (2008) , Merkler et al. (2005) , 
and Thiessen et al. (2013) 
Increase in T 2 * and decrease in 
grey-white matter frequency contrast 
with demyelination 
Lee et al. (2012) 
Axonal damage Reduced parallel apparent diffusion 
coefﬁcient with DWI 
Wu et al. (2008) 
Decrease in axial diffusivity with DTI Sun et al. (2006) , Xie et al. (2010) , and 
Zhang et al. (2012) 
Changes in deep grey matter Decrease in MTR Fjaer et al. (2013) 
Lysolecithin BBB breakdown Enhancement with Gd Ford et al. (1990) 
White matter changes Decrease in MTR with demyelination Deloire-Grassin et al. (2000) , Dousset et al. 
(1995) , and McCreary et al. (2009) 
Decrease in axial diffusivity and 
fractional anisotropy and increase in 
radial diffusivity with DTI with 
demyelination 
DeBoy et al. (2007) 
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 5 months of age ( Enriquez-Algeciras et al., 2011 ). 
3. Summary of MRI results across animal models of MS 
In summary, a variety of MRI methods have been used to study a
wide range of pathologies across the key animal models used to study
MS — EAE, TMEV, cuprizone and lysolecithin. The EAE model is the
most extensively studied, which may be one of the reasons that such
diverse pathology has been reported. All of the animal models show
white matter damage. Observations are summarized below ( Table 1 ). 
4. Incorporation of MRI into animal model studies of MS to 
increase understanding of MS pathology 
MRI studies of models of MS have speciﬁc and obvious advantages.
One advantage is the ability to image before and during disease pro-
gression in an individual animal. As a result, changes may be followed
over time, ultimately reducing animal numbers and enabling one to
compare within a single animal with statistics ( Nathoo et al., 2014 ). 
A signiﬁcant beneﬁt of using MRI in animal model studies is that
it allows for the development of methods that can be translated to
clinical use. This includes the development of MRI sequences and
new contrast agents. Examples of new contrast agents that are not
yet approved in humans include Gf and contrast agents based on
VCAM-1 and ICAM-1. In EAE, Gf has shown areas of disrupted BBB
( Bendszus et al., 2008 ; Wuerfel et al., 2010 ). Although Gd-enhanced
MRI is currently the gold standard for assessing BBB breakdown with
MRI in MS, Gf has been demonstrated to be more sensitive than Gd
for this purpose ( Stoll et al., 2009 ). 
One of the contrast agents initially used in EAE that has been
translated for use in MS patients is the iron-based USPIOs. Studies
in EAE comparing BBB breakdown (using Gd or Gf) with inﬁltration
of monocytes into the CNS (using USPIOs) have been particularly
instructive, as they have commonly observed that there appears to be
a mismatch between BBB breakdown and monocyte migration into
the CNS ( Floris et al., 2004 ; Ladewig et al., 2009 ; Rausch et al., 2003 ).
Furthermore, some lesions are only detected using USPIOs in EAE
( Tysiak et al., 2009 ; Ladewig et al., 2009 ). In recent years, studies have
been carried out in MS patients comparing Gd with USPIOs ( Dousset
et al., 2006 ; Tourdias et al., 2012 ; Vellinga et al., 2008 ). Remarkably,
these human studies have come to the same conclusion as animal
studies — USPIOs may be present in areas that appear to have an
intact BBB as they do not show Gd-enhancement ( Dousset et al., 2006 ;
Tourdias et al., 2012 ; Vellinga et al., 2008 ). 
One of the greatest advantages of using animal models is the abil-
ity to correlate MRI metrics with histopathology to validate the sen-
sitivity and speciﬁcity of imaging methods. This allows for improved
interpretation of MRI ﬁndings in patient studies. An example of an
instance where MRI has been combined with histopathology to val-
idate the substrates seen in MRI is in the usage of susceptibility-
weighted imaging in the EAE model. Iron accumulation is an aspect of
MS pathophysiology, and animal imaging in combination with patho-
logical analysis has veriﬁed that susceptibility-weighted imaging can
detect tissue iron ( Nathoo et al., 2013a ) which has also been observed
in MS ( Hopp et al., 2010 ). It would be beneﬁcial to increase the num-
ber of such studies, although some may argue that correlating MRI
with histology is too challenging. In fact, this is relatively easy to do
within a useful range of spatial accuracy. Histological sections can
easily be prepared at 10 μm in thickness or less, while the usual slice
thickness for MRI is ˜  500–1000 μm. Therefore, with serial section-
ing, a histological section can easily be localized within an MRI slice
using anatomical markers. With the inevitable limitations faced in
obtaining human MS tissue at various stages of disease progression,
more animal imaging studies using histology as a correlate need to be
conducted. However, one has to be wary that animal models do not
mimic all aspects of MS accurately. Animal models are continuing to develop, including models which
are more speciﬁc to either subsets of MS pathology, or to MS patho-
physiology as a whole. As these evolve, they will need to be studied
with MRI to determine how the imaging phenotype experimentally
relates to disease clinically. As MRI is now a cornerstone of both ani-
mal studies and patient research, it forms a vital methodological link
between basic research and clinical implementation. 
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